Upgrade to SI Premium - Free Trial

Edwards Lifesciences (EW) PT Raised at Bernstein SocGen After 'Another strong, clean quarter'

April 24, 2026 8:29 AM
Bernstein SocGen Group analyst Lee Hambright raised the price target on Edwards Lifesciences (NYSE: EW) to $96.00 (from $95.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change